MAPT and Alzheimer disease: Regulation of GSk3β activity by proteolysis was first reported in the brain, where it was found associated with Tau hyperphosphorylation in Alzheimer’s disease (Jin et al., 2015); the present study provides the first demonstration of its occurrence in skeletal muscle, where it leads to phosphorylation of glycogen synthase, as indicated by the correlation found between GSK3β cleavage and blood sugar.